What are the best treatments for Central Core Disease?

There is currently no curative treatment for Central Core Disease; instead, clinical management focuses on supportive care, physical therapy, and the avoidance of specific anesthetic agents. Treatment for Central Core Disease is highly personalized, requiring a multidisciplinary team to address muscle weakness, orthopedic complications, and the critical risk of malignant hyperthermia.

How is Central Core Disease managed clinically?

Management of Central Core Disease (CCD) is primarily supportive. Because patients with Central Core Disease possess a genetic predisposition to malignant hyperthermia (MH), the most critical clinical intervention is the absolute avoidance of triggering anesthetic agents, such as volatile gases and succinylcholine. Patients should carry a medical alert bracelet at all times to ensure emergency responders are aware of this risk.

What non-pharmacological interventions are used?

Physical and occupational therapies are the cornerstones of daily management for those living with Central Core Disease. These therapies aim to maintain joint range of motion, prevent contractures, and optimize functional independence. Common interventions include:

• Physical Therapy: Focused on low-impact strengthening and maintaining mobility.


• Orthopedic Monitoring: Regular screening for scoliosis and hip dislocation, which are more frequent in patients with Central Core Disease.


• Occupational Therapy: Adapting daily activities to compensate for proximal muscle weakness.


• Respiratory Support: Baseline pulmonary function testing to monitor for restrictive lung disease.

Which specialists should be on the care team?

Due to the multisystem nature of Central Core Disease, care should be coordinated by a center specializing in neuromuscular disorders. Your care team should include a neurologist, a physiatrist (physical medicine and rehabilitation specialist), an orthopedic surgeon, a pulmonologist, and an anesthesiologist experienced in MH-susceptible conditions. With 89 community members sharing their experiences on DiseaseMaps.org, many find that connecting with a specialized neuromuscular clinic significantly improves their quality of life.

Are there emerging treatments for Central Core Disease?

While no disease-modifying drug currently exists for Central Core Disease, research is ongoing. Clinical trials are investigating the role of calcium channel modulation to address the underlying ryanodine receptor (RYR1) dysfunction. Patients are encouraged to monitor platforms like ClinicalTrials.gov for updates on pharmacological research specifically targeting RYR1-related myopathies.

Next steps

• Consult a neuromuscular specialist to establish a baseline pulmonary and orthopedic care plan.


• Wear a medical alert bracelet specifying your risk of malignant hyperthermia.


• Join the 89 members on DiseaseMaps.org to share experiences and learn about local specialists.


• Discuss genetic counseling with your team to understand the implications for family planning.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult your personal healthcare team for treatment decisions tailored to your specific clinical needs.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Central Core Disease.


• Orphanet: Central Core Disease (ORPHA:205).


• OMIM (Online Mendelian Inheritance in Man): #117000 (RYR1-related myopathies).


• Malignant Hyperthermia Association of the United States (MHAUS).